Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer

AIM: To investigate second-line chemotherapy in gemcitabine-pretreated patients with advanced or metastatic pancreatic cancer [(frequency, response, outcome, course of carbohydrate antigen 19-9 (CA 19-9)]. METHODS: This retrospective study included all patients with advanced or metastatic pancreatic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Altwegg, Romain, Ychou, Marc, Guillaumon, Vanessa, Thezenas, Simon, Senesse, Pierre, Flori, Nicolas, Mazard, Thibault, Caillo, Ludovic, Faure, Stéphanie, Samalin, Emmanuelle, Assenat, Eric
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Co., Limited 2012
Schlagworte:
Brief Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319962/
https://ncbi.nlm.nih.gov/pubmed/22493549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i12.1357
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge